Literature DB >> 14521538

Use of recombinant human DNase in a premature infant with recurrent atelectasis.

Serhan Küpeli1, Ozlem Teksam, Deniz Dogru, Murat Yurdakök.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14521538     DOI： 10.1046/j.1442-200x.2003.01791.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN： 1328-8067            Impact factor:   1.524


× No keyword cloud information.
  2 in total

1.  Efficacy and safety of nebulized recombinant human DNase as rescue treatment for persistent atelectasis in newborns: case-series.

Authors:  Omer Erdeve; Nurdan Uras; Begum Atasay; Saadet Arsan
Journal:  Croat Med J       Date:  2007-04       Impact factor: 1.351

2.  Safety of recombinant human deoxyribonuclease as a rescue treatment for persistent atelectasis in newborns.

Authors:  Atiye Fedakar; Cavit Aydogdu; Ali Fedakar; Murat Ugurlucan; Semih Bolu; Marina Iskender
Journal:  Ann Saudi Med       Date:  2012 Mar-Apr       Impact factor: 1.526
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.